CS logo
small CS logo
Icahn School of Medicine at Mount Sinai Beth Israel

New York, New York, United States
Medical school in New York City, New York
1 Gustave L. Levy Pl, New York, NY 10029

About Icahn School of Medicine at Mount Sinai Beth Israel


The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City. Chartered by Mount Sinai Hospital in 1963, it is the academic teaching arm of The Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Icahn School of Medicine at Mount Sinai Beth Israel


During the past decade, Icahn School of Medicine at Mount Sinai Beth Israel conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Icahn School of Medicine at Mount Sinai Beth Israel


According to Clinical.Site data, the most researched conditions in "Icahn School of Medicine at Mount Sinai Beth Israel" are "Nonalcoholic Steatohepatitis" (3 trials), "COVID-19" (2 trials), "Colorectal Cancer" (1 trials), "Nonalcoholic Fatty Liver Disease" (1 trials) and "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials). Many other conditions were trialed in "Icahn School of Medicine at Mount Sinai Beth Israel" in a lesser frequency.

Clinical Trials Intervention Types at Icahn School of Medicine at Mount Sinai Beth Israel


Most popular intervention types in "Icahn School of Medicine at Mount Sinai Beth Israel" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "SEL" (3 trials), "Placebo" (2 trials), "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials) and "Remdesivir" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Icahn School of Medicine at Mount Sinai Beth Israel


The vast majority of trials in "Icahn School of Medicine at Mount Sinai Beth Israel" are 8 trials for "All" genders.

Clinical Trials Status at Icahn School of Medicine at Mount Sinai Beth Israel


Currently, there are NaN active trials in "Icahn School of Medicine at Mount Sinai Beth Israel". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Icahn School of Medicine at Mount Sinai Beth Israel, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Icahn School of Medicine at Mount Sinai Beth Israel, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".